Rhythm Pharmaceuticals Competitors and Similar CompaniesClear all
Rhythm Pharmaceuticals's competitors and similar companies include UCB, Livzon Pharmaceutical Group, Cadila Pharmaceuticals and EMS Pharma.
 Rhythm Pharmaceuticals Rhythm is a biopharmaceutical company focused on developing and commercializing peptide therapeutics. |  UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions. |  Livzon Pharmaceutical Group Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products. |  Cadila Pharmaceuticals Cadila Pharmaceuticals is a company that develops and manufactures medicines for patients. |  EMS Pharma EMS Pharma is a company that specializes in the research, development, and manufacturing of pharmaceuticals. | |
Founding Date | Founding Date 2008 | Founding Date 1928 | Founding Date 1985 | Founding Date 1951 | Founding Date 1964 |
Type | Type Public | Type Public | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations Boston, US HQ | Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more | Locations Zhuhai, CN HQ Chengdu, CN Qingyuan, CN Shanghai, CN Shaoguan, CN Shenzhen, CN Zhuhai, CN | Locations BR HQ | |
Employees | Employees 2222% increase | Employees 9,052 | Employees 9,067 | Employees 8,5201% increase | Employees 12,7441% increase |
Valuation ($) | Valuation ($) 3 b | Valuation ($) 34.3 b | Valuation ($) 4.2 b | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $189.8m (FY, 2025) | Revenue (est.) €7.4b (FY, 2025) | Revenue (est.) ¥11.7b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods $19.5m (FY, 2025) | Cost of goods €1.4b (FY, 2025) | Cost of goods ¥4.1b (FY, 2025) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit $170.3m (FY, 2025) | Gross profit €7.2b (FY, 2025) | Gross profit ¥7.8b (FY, 2025) | Gross profit N/A | Gross profit N/A |
Net income | Net income ($196.5m) (FY, 2025) | Net income €1.6b (FY, 2025) | Net income ¥2.4b (FY, 2025) | Net income N/A | Net income N/A |
For sources of this data, please see the company profile
View Company Profiles
UCB
HQ
Brussels, BE
Employees
9,052
UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
View companyLivzon Pharmaceutical Group
HQ
Zhuhai, CN
Employees
9,067
Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products.
View companyCadila Pharmaceuticals
HQ
Bavla, IN
Employees
8,520↑ 1% increase
Cadila Pharmaceuticals is a company that develops and manufactures medicines for patients.
View companyEMS Pharma
HQ
BR
Employees
12,744↑ 1% increase
EMS Pharma is a company that specializes in the research, development, and manufacturing of pharmaceuticals.
View company